Haemonetics Corporation Revenue from Contract with Customer, Including Assessed Tax
Haemonetics Corporation (HAE) reported Revenue from Contract with Customer, Including Assessed Tax of $339.38 million for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-08-06
- Haemonetics Corporation revenue from contract with customer, including assessed tax for the quarter ending 2026-06-27 was $339.38M, a 5.60% increase year-over-year.
- Haemonetics Corporation revenue from contract with customer, including assessed tax for the quarter ending 2026-03-28 was $346.35M, a 4.76% increase year-over-year.
- Haemonetics Corporation revenue from contract with customer, including assessed tax for the quarter ending 2025-12-27 was $338.97M, a 2.75% decline year-over-year.
- Haemonetics Corporation revenue from contract with customer, including assessed tax for the quarter ending 2025-09-27 was $327.31M, a 5.27% decline year-over-year.
- Haemonetics Corporation revenue from contract with customer, including assessed tax for fiscal 2026 was $1.33B, a 1.97% decline from fiscal 2025.
- Haemonetics Corporation revenue from contract with customer, including assessed tax for fiscal 2025 was $1.36B, a 3.95% increase from fiscal 2024.
- Haemonetics Corporation revenue from contract with customer, including assessed tax for fiscal 2024 was $1.31B, a 12.01% increase from fiscal 2023.
- Haemonetics Corporation revenue from contract with customer, including assessed tax for fiscal 2023 was $1.17B, a 17.67% increase from fiscal 2022.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-27 | $339.38M 10-Q · filed 2026-08-06 | $685.73M derived: sum of 2 quarters · filed 2026-08-06 | $1.02B derived: sum of 3 quarters · filed 2026-08-06 | $1.35B derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-28 | $346.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $685.32M derived: sum of 2 quarters · filed 2026-05-20 | $1.01B derived: sum of 3 quarters · filed 2026-05-20 | $1.33B 10-K · filed 2026-05-20 |
| 2025-12-27 | $338.97M 10-Q · filed 2026-02-05 | $666.28M derived: sum of 2 quarters · filed 2026-02-05 | $987.68M 10-Q · filed 2026-02-05 | $1.32B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-09-27 | $327.31M 10-Q · filed 2025-11-06 | $648.71M 10-Q · filed 2025-11-06 | $979.31M derived: sum of 3 quarters · filed 2026-08-06 | $1.33B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-28 | $321.39M 10-Q · filed 2026-08-06 | $651.99M derived: sum of 2 quarters · filed 2026-08-06 | $1.00B derived: sum of 3 quarters · filed 2026-08-06 | $1.35B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-29 | $330.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $679.14M derived: sum of 2 quarters · filed 2026-05-20 | $1.02B derived: sum of 3 quarters · filed 2026-05-20 | $1.36B 10-K · filed 2026-05-20 |
| 2024-12-28 | $348.54M 10-Q · filed 2026-02-05 | $694.05M derived: sum of 2 quarters · filed 2026-02-05 | $1.03B 10-Q · filed 2026-02-05 | |
| 2024-09-28 | $345.51M 10-Q · filed 2025-11-06 | $681.68M 10-Q · filed 2025-11-06 | ||
| 2024-06-29 | $336.17M 10-Q · filed 2025-08-07 | |||
| 2024-03-30 | $1.31B 10-K · filed 2026-05-20 | |||
| 2023-04-01 | $1.17B 10-K · filed 2025-05-21 | |||
| 2022-04-02 | $993.20M 10-K · filed 2024-05-20 | |||
| 2021-04-03 | $225.03M 10-K · filed 2021-05-26 | $465.40M derived: sum of 2 quarters · filed 2021-05-26 | $674.89M derived: sum of 3 quarters · filed 2021-05-26 | $870.46M 10-K · filed 2023-05-22 |
| 2020-12-26 | $240.37M 10-K · filed 2021-05-26 | $449.86M derived: sum of 2 quarters · filed 2021-05-26 | $645.43M derived: sum of 3 quarters · filed 2021-05-26 | $883.93M derived: sum of 4 quarters · filed 2021-05-26 |
| 2020-09-26 | $209.49M 10-K · filed 2021-05-26 | $405.06M derived: sum of 2 quarters · filed 2021-05-26 | $643.55M derived: sum of 3 quarters · filed 2021-05-26 | $902.52M derived: sum of 4 quarters · filed 2021-05-26 |
| 2020-06-27 | $195.58M 10-K · filed 2021-05-26 | $434.07M derived: sum of 2 quarters · filed 2021-05-26 | $693.04M derived: sum of 3 quarters · filed 2021-05-26 | $945.61M derived: sum of 4 quarters · filed 2021-05-26 |
| 2020-03-28 | $238.49M 10-K · filed 2021-05-26 | $497.46M derived: sum of 2 quarters · filed 2021-05-26 | $750.03M derived: sum of 3 quarters · filed 2021-05-26 | $988.48M 10-K · filed 2022-05-25 |
| 2019-12-28 | $258.97M 10-K · filed 2021-05-26 | $511.54M derived: sum of 2 quarters · filed 2021-05-26 | $749.99M derived: sum of 3 quarters · filed 2021-05-26 | $999.28M derived: sum of 4 quarters · filed 2021-05-26 |
| 2019-09-28 | $252.57M 10-K · filed 2021-05-26 | $491.02M derived: sum of 2 quarters · filed 2021-05-26 | $740.31M derived: sum of 3 quarters · filed 2021-05-26 | $987.67M derived: sum of 4 quarters · filed 2021-05-26 |
| 2019-06-29 | $238.45M 10-K · filed 2021-05-26 | $487.75M derived: sum of 2 quarters · filed 2021-05-26 | $735.10M derived: sum of 3 quarters · filed 2021-05-26 | $976.68M derived: sum of 4 quarters · filed 2021-05-26 |
| 2019-03-30 | $249.29M 10-K · filed 2020-05-20 | $496.65M derived: sum of 2 quarters · filed 2020-05-20 | $738.23M derived: sum of 3 quarters · filed 2020-05-20 | $967.58M 10-K · filed 2021-05-26 |
| 2018-12-29 | $247.36M 10-K · filed 2020-05-20 | $488.94M derived: sum of 2 quarters · filed 2020-05-20 | $718.28M derived: sum of 3 quarters · filed 2020-05-20 | $951.84M derived: sum of 4 quarters · filed 2020-05-20 |
| 2018-09-29 | $241.58M 10-K · filed 2020-05-20 | $241.58M 10-K · filed 2019-05-22 | $704.48M derived: sum of 3 quarters · filed 2020-05-20 | $938.52M derived: sum of 4 quarters · filed 2020-05-20 |
| 2018-06-30 | $229.35M 10-K · filed 2020-05-20 | $462.90M derived: sum of 2 quarters · filed 2020-05-20 | $696.94M derived: sum of 3 quarters · filed 2020-05-20 | $922.32M derived: sum of 4 quarters · filed 2020-05-20 |
| 2018-03-31 | $233.55M 10-K · filed 2019-05-22 | $467.60M derived: sum of 2 quarters · filed 2019-05-22 | $692.97M derived: sum of 3 quarters · filed 2019-05-22 | $903.92M 10-K · filed 2020-05-20 |
| 2017-12-30 | $234.04M 10-K · filed 2019-05-22 | $459.42M derived: sum of 2 quarters · filed 2019-05-22 | $670.37M derived: sum of 3 quarters · filed 2019-05-22 | |
| 2017-09-30 | $225.38M 10-K · filed 2019-05-22 | $436.33M derived: sum of 2 quarters · filed 2019-05-22 | ||
| 2017-07-01 | $210.95M 10-K · filed 2019-05-22 | |||
| 2017-04-01 | $886.12M 10-K · filed 2019-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |